New Product Development
The global outsourced testing services market is expected to be worth $36.4 billion in 2022 and to grow at a 7.7% CAGR to $76.3 billion by 2032. According to a new Future Market Insights analysis, pharma/biopharmaceuticals testing will command a 40.8% share of the global market in 2021. The increase in the number of infectious …
Continue reading “Outsourced Testing Services Market is expected to reach US$ 76.3 Billion by 2032”
The global sphingolipids market was valued at approximately US$ 564.0 Million in 2021, with the global market expected to grow at a 5.1% CAGR to an anticipated valuation of approximately US$ 991.8 Million by the end of 2032. As of 2021, conventional lipid-based drug delivery systems (LBDDS) account for 61.9% of the worldwide sphingolipids market. …
Continue reading “Sphingolipids Market is expected to reach US$ 991.8 Million by 2032”
The global Point-Of-Care Breathalyser Market is expected to be worth US$ 385.7 million in 2022, with a CAGR of 5.5% to reach US$ 658.9 million by 2032. Alcohol usage is being blamed for the increase in growth. The point-of-care breathalyser market grew at a CAGR of 5.2% between 2016 and 2021. Breathalyzer is a non-invasive …
Continue reading “Point-Of-Care Breathalyser Market to expand at a 5.5% value CAGR by 2032”
Over the projected period of 2022 to 2032, global demand for drug formulation is expected to grow at a 5.6% CAGR. The pharmaceutical formulations market is expected to be worth $1.58 trillion by 2022. Oral formulations are expected to rise exponentially at a CAGR of 6.0% during the forecast period, according to the study. As …
Continue reading “Drug Formulation Market is expected to reach US$ 2.87 Trillion by 2032”
During the forecast period, the global Inhalation and Nasal Spray Generic Drugs Market is expected to grow at a moderate rate of 8.96%. The market for inhalation and nasal spray generic pharmaceuticals is currently valued at US$ 20.78 billion in 2023. The market for inhalation and nasal spray generic pharmaceuticals is expected to reach a …
The Orthopedic Navigation Systems Market revenues were estimated at US$ 2.4 Billion in 2022 and is anticipated to grow at a CAGR of 16.9% from 2023 to 2033, according to a recently published Future Market Insights report. By the end of 2033, the market is expected to reach US$ 10.4 Billion. Increasing financing initiatives from the government for surgical navigation system research …
According to a recently published analysis report by Future Market Insights, the global market for terminal sterilisation services is expected to generate US$9.1 billion in sales by 2021. With a predicted growth between 2022 and 2032, at 12.7%, the market is likely to reach a valuation of US$ 33.5 Bn by 2032. The highest revenue-generating segment is …
The global conjunctivitis market size was predicted to be valued at US$ 1825.8 Million. The market is expected to reach nearly US$ 3208.7 Million by 2032, with a growing CAGR of 5.8% from 2022 to 2032. Swelling of conjunctiva (tissue covering white portion of eye) due to allergy is known as allergic conjunctivitis. Allergic conjunctivitis is caused due …
Continue reading “Conjunctivitis Market is expected to reach US$ 3,208.7 Million by 2032”
A recently published study by Future Market Insights, the global pleural disease therapeutics market is expected to accumulate a valuation of US$ 9.4 billion by 2033, registering a CAGR of 6.5% across the forthcoming decade. Increasing prevalence of congestive heart failure, and other heart conditions, lung conditions, pneumonia, cancer and tuberculosis is estimated to propel the need …
According to Future Market Insights, the optic atrophy management market is slated to experience a CAGR of 4.9% from 2023 to 2033, anticipated to reach a valuation of US$ 15.63 billion. An existing medical study in gene replacement therapy found a satisfactory safety record but poor medicinal result durability. The findings of the study are encouraging, and …